AGAP2 and non-small cell lung carcinoma: Interestingly, MALAT1 and AGAP2-AS1 were found to be elevated in EVs of smokers and NSCLC patients when compared to controls, indicating that these lncRNAs should be probed for their role as early diagnostic markers in larger cohorts.